Research

Mixed

Continuous Positive Airway Pressure (CPAP) therapy effectively improves daytime sleepiness and quality of life in Obstructive Sleep Apnoea (OSA) patients, but its impact on cardiometabolic outcomes is uncertain and secondary prevention trials have failed to demonstrate significant modification of cardiovascular events.

CPAP is the most effective treatment for stopping snoring and fixing daytime sleepiness in OSA patients. However, do not expect it to automatically fix your heart health or blood sugar levels, as evidence for those benefits is weak. If you struggle with the mask, talk to your doctor about alternatives like oral appliances or nerve stimulation, as adherence is a major hurdle.

GoodQualifiesHIGH confidence
Although CPAP is highly effective in improving daytime sleepiness, quality of life, and other symptoms, its effect on cardiometabolic complications is uncertain. ... secondary prevention trials have failed to demonstrate a significant modifying effect on CV outcomes
Maria Stanczyk et al. · Journal of Sleep Research · 2025

Why this rating

Based on multiple RCTs and large real-world studies cited, though the paper highlights methodological limitations in CV trials.

Source

Management of Adult Obstructive Sleep Apnoea: Many Questions, Not Enough Answers!

Maria Stanczyk et al. · Journal of Sleep Research · 2025

DOI 10.1111/jsr.70047

narrative_reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →